Institutional investors purchased a net $11.5 million shares of INSM during the quarter ended September 2013 and now own 69.40% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SECTORAL ASSET MANAGEMENT, INC. Bought 1.4 Million shares of Insmed Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.4 Million shares of Insmed Inc
MILLENNIUM MANAGEMENT LLC Bought 1.3 Million shares of Insmed Inc